Geron
GERN
#6280
Rank
โ‚น75.12 B
Marketcap
โ‚น117.69
Share price
3.15%
Change (1 day)
-65.08%
Change (1 year)

Geron (GERN) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น10.95 Billion

According to Geron's latest financial reports the company's total debt is โ‚น10.95 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Geron - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น10.44 B46.02%
2023-12-31โ‚น7.15 B55%
2022-12-31โ‚น4.61 B12.7%
2021-12-31โ‚น4.09 B88.34%
2020-12-31โ‚น2.17 B1093.37%
2019-12-31โ‚น0.18 B
2018-12-31N/A
2005-12-31โ‚น2.47 M-98.24%
2004-12-31โ‚น0.14 B-50.14%
2003-12-31โ‚น0.28 B-77.41%
2002-12-31โ‚น1.24 B48.47%
2001-12-31โ‚น0.84 B-46.02%
2000-12-31โ‚น1.55 B95.7%
1999-12-31โ‚น0.79 B107.89%
1998-12-31โ‚น0.38 B323.37%
1997-12-31โ‚น90.38 M-10.2%
1996-12-31โ‚น0.10 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
โ‚น49.58 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.240 T 20,357.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น35.43 B 223.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น3.70 B-66.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น4.39 B-59.89%๐Ÿ‡บ๐Ÿ‡ธ USA